Correlation Between Monopar Therapeutics and Science
Specify exactly 2 symbols:
By analyzing existing cross correlation between Monopar Therapeutics and Science Applications International, you can compare the effects of market volatilities on Monopar Therapeutics and Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Science.
Diversification Opportunities for Monopar Therapeutics and Science
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Monopar and Science is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Science Applications Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Science Applications and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Science Applications has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Science go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Science
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 36.94 times more return on investment than Science. However, Monopar Therapeutics is 36.94 times more volatile than Science Applications International. It trades about 0.02 of its potential returns per unit of risk. Science Applications International is currently generating about -0.02 per unit of risk. If you would invest 4,146 in Monopar Therapeutics on November 25, 2024 and sell it today you would lose (121.00) from holding Monopar Therapeutics or give up 2.92% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 85.71% |
Values | Daily Returns |
Monopar Therapeutics vs. Science Applications Internati
Performance |
Timeline |
Monopar Therapeutics |
Science Applications |
Monopar Therapeutics and Science Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Monopar Therapeutics and Science
The main advantage of trading using opposite Monopar Therapeutics and Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Science will offset losses from the drop in Science's long position.Monopar Therapeutics vs. Anebulo Pharmaceuticals | ||
Monopar Therapeutics vs. Acrivon Therapeutics, Common | ||
Monopar Therapeutics vs. Pmv Pharmaceuticals | ||
Monopar Therapeutics vs. Molecular Partners AG |
Science vs. Braskem SA Class | ||
Science vs. Aldel Financial II | ||
Science vs. CF Industries Holdings | ||
Science vs. Eastman Chemical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data |